TY - JOUR
T1 - PDCD10 gene mutations in multiple cerebral cavernous malformations
AU - Cigoli, Maria S ole
AU - Avemaria, Francesca
AU - De Benedetti, Stefano
AU - Gesu, Giovanni P.
AU - Accorsi, Lucio G iordano
AU - Parmigiani, Stefano
AU - Corona, Maria F ranca
AU - Capra, Valeria
AU - Mosca, Andrea
AU - Giovannini, Simona
AU - Notturno, Francesca
AU - Ciccocioppo, Fausta
AU - Volpi, Lilia
AU - Estienne, Margherita
AU - De Michele, Giuseppe
AU - Antenora, Antonella
AU - Bilo, Leda
AU - Tavoni, Antonietta
AU - Zamponi, Nelia
AU - Alfei, Enrico
AU - Baranello, Giovanni
AU - Riva, Daria
AU - Penco, Silvana
PY - 2014
Y1 - 2014
N2 - Cerebral cavernous malformations (CCMs) are vascular abnormalities that may cause seizures, intracerebral haemorrhages, and focal neurological deficits. Familial form shows an autosomal dominant pattern of inheritance with incomplete penetrance and variable clinical expression. Three genes have been identified causing familial CCM: KRIT1/CCM1, MGC4607/CCM2, and PDCD10/CCM3. Aim of this study is to report additional PDCD10/CCM3 families poorly described so far which account for 10-15% of hereditary cerebral cavernous malformations. Our group investigated 87 consecutive Italian affected individuals (i.e. positive Magnetic Resonance Imaging) with multiple/familial CCM through direct sequencing and Multiplex Ligation-Dependent Probe Amplification (MLPA) analysis. We identified mutations in over 97.7% of cases, and PDCD10/CCM3 accounts for 13.1%. PDCD10/CCM3 molecular screening revealed four already known mutations and four novel ones. The mutated patients show an earlier onset of clinical manifestations as compared to CCM1/CCM2 mutated patients. The study of further families carrying mutations in PDCD10/CCM3 may help define a possible correlation between genotype and phenotype; an accurate clinical follow up of the subjects would help define more precisely whether mutations in PDCD10/CCM3 lead to a characteristic phenotype.
AB - Cerebral cavernous malformations (CCMs) are vascular abnormalities that may cause seizures, intracerebral haemorrhages, and focal neurological deficits. Familial form shows an autosomal dominant pattern of inheritance with incomplete penetrance and variable clinical expression. Three genes have been identified causing familial CCM: KRIT1/CCM1, MGC4607/CCM2, and PDCD10/CCM3. Aim of this study is to report additional PDCD10/CCM3 families poorly described so far which account for 10-15% of hereditary cerebral cavernous malformations. Our group investigated 87 consecutive Italian affected individuals (i.e. positive Magnetic Resonance Imaging) with multiple/familial CCM through direct sequencing and Multiplex Ligation-Dependent Probe Amplification (MLPA) analysis. We identified mutations in over 97.7% of cases, and PDCD10/CCM3 accounts for 13.1%. PDCD10/CCM3 molecular screening revealed four already known mutations and four novel ones. The mutated patients show an earlier onset of clinical manifestations as compared to CCM1/CCM2 mutated patients. The study of further families carrying mutations in PDCD10/CCM3 may help define a possible correlation between genotype and phenotype; an accurate clinical follow up of the subjects would help define more precisely whether mutations in PDCD10/CCM3 lead to a characteristic phenotype.
UR - http://www.scopus.com/inward/record.url?scp=84937217890&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937217890&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0110438
DO - 10.1371/journal.pone.0110438
M3 - Article
C2 - 25354366
AN - SCOPUS:84908592952
VL - 9
SP - e110438
JO - PLoS One
JF - PLoS One
SN - 1932-6203
IS - 10
ER -